Union Station Dock

AltaThera Pharmaceuticals, based in Chicago, IL, is a precision medicine company dedicated to enhancing patient care through innovative science and individualized treatment solutions for cardiovascular drug therapy. With a focus on addressing the global arrhythmia epidemic, AltaThera is committed to bridging the gap between scientific innovation and clinical decision-making. The company's flagship product, Sotalol IV, represents a new formulation of a trusted antiarrhythmic drug that aims to streamline patient care by converting inpatient procedures to outpatient settings, ultimately reducing hospital stays. By leveraging clinical data to optimize the use of existing medications, AltaThera strives to improve treatment outcomes for diverse patient populations. Generated from the website